| Xcytrin (motexafin gadolinum) / AbbVie |
NCT00022256: Motexafin Gadolinium Plus Radiation Therapy to the Brain in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
|
|
| Completed | 2 | | US | motexafin gadolinium, radiation therapy | Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI) | Brain and Central Nervous System Tumors | 04/03 | 04/03 | | |
NCT00096837: A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma |
|
|
| Completed | 2 | 25 | US | Motexafin Gadolinium Injection | Pharmacyclics LLC. | Multiple Myeloma | | | | |
NCT00134186: Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer |
|
|
| Completed | 2 | 43 | US | motexafin gadolinium | Pharmacyclics LLC. | Carcinoma, Renal Cell, Urogenital Neoplasms, Urologic Neoplasms, Kidney Neoplasms | | | | |
NCT00086034: Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma |
|
|
| Completed | 2 | 35 | US | Motexafin gadolinium | Pharmacyclics LLC. | Lymphoma, Non-Hodgkin's Lymphoma | | | | |
NCT00129844: Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer |
|
|
| Completed | 2 | 108 | US, Canada | Motexafin Gadolinium | Pharmacyclics LLC. | Adenocarcinoma, Non-Small-Cell Lung Carcinoma, Lung Neoplasms | 06/07 | 12/07 | | |
NCT00365183: Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer |
|
|
| Terminated | 2 | 74 | US | Motexafin gadolinium and pemetrexed, MGd and Alimta® | Pharmacyclics LLC. | Non-Small Cell Lung Carcinoma | 01/08 | 06/08 | | |
NCT00373204: Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere) |
|
|
| Terminated | 2 | 50 | US, Canada, RoW | Motexafin Gadolinium, MGd and Docetaxtel | Pharmacyclics LLC. | Lung Cancer | 02/08 | 05/08 | | |
NCT00100711: Study of Motexafin Gadolinium (MGd) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma |
|
|
| Terminated | 2 | 27 | US | Motexafin Gadolinium | Pharmacyclics LLC. | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | 02/10 | | | |
NCT00387790: Motexafin Gadolinium and Radiation Therapy in Treating Young Patients With Pontine Glioma |
|
|
| Completed | 2 | 64 | US | motexafin gadolinium, gadolinium texaphyrin, Gd (III) Texaphryin, Gd-Tex, PCI-0120, Xcytrin, 3-dimensional conformal radiation therapy, 3D conformal radiation therapy, 3D-CRT | National Cancer Institute (NCI) | Untreated Childhood Brain Stem Glioma | 04/10 | 04/10 | | |
NCT00717587: Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer |
|
|
| Unknown status | 2 | 20 | US | motexafin gadolinium, sunitinib malate, comparative genomic hybridization, gene expression analysis, mutation analysis, polymorphism analysis, immunohistochemistry staining method, iodine I-124 girentuximab, laboratory biomarker analysis, pharmacological study, adjuvant therapy, neoadjuvant therapy, therapeutic conventional surgery | Abramson Cancer Center of the University of Pennsylvania, National Cancer Institute (NCI) | Kidney Cancer | 07/10 | | | |
| Unknown status | 2 | 43 | Europe | motexafin gadolinium, temozolomide, adjuvant therapy, quality-of-life assessment, radiation therapy | Children's Cancer and Leukaemia Group | Brain and Central Nervous System Tumors | | | | |
NCT00121420: Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases |
|
|
| Terminated | 2 | 45 | US, Canada | Motexafin gadolinium | Pharmacyclics LLC. | Neoplasm Metastasis, Brain Neoplasms | | | | |
NCT01549886: Phase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's Lymphoma |
|
|
| Terminated | 2 | 5 | US | Y-90-Zevalin, [90Y]- ibritumomab tiuxetan (Zevalin), Moxtezafin Gadolinium, MGD, Rituximab | Spectrum Pharmaceuticals, Inc | Non-Hodgkin's Lymphoma | 06/14 | 05/15 | | |
NCT00076401: A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) |
|
|
| Terminated | 2 | 27 | US | Motexafin gadolinium | Pharmacyclics LLC. | Leukemia, Leukemia, Lymphocytic, Chronic | | | | |
NCT00089284: Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL |
|
|
| Terminated | 1/2 | 30 | US | Rituxan, rituximab IDEC-C2B8, motexafin gadolinium, MGd, Xcytrin® (motexafin gadolinium) Injection,, NSC 695238, 111Indium-Zevalin and 90Yttrium-Zevalin, Ibritumomab-tiuxetan | Northwestern University, Robert H. Lurie Cancer Center | Non-Hodgkin's Lymphoma (NHL) | 01/07 | 08/08 | | |
NCT00290004: Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma |
|
|
| Completed | 1/2 | 35 | US | motexafin gadolinium | Pharmacyclics LLC. | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Leukemia, Lymphoma | 02/07 | 02/07 | | |
RTOG 0513, NCT00305864: Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma |
|
|
| Completed | 1/2 | 118 | US | 3-Dimensional Conformal Radiation Therapy, 3-dimensional radiation therapy, 3D CONFORMAL RADIATION THERAPY, 3D CRT, 3D-CRT, Conformal Therapy, Radiation Conformal Therapy, Motexafin Gadolinium, API-GP3, gadolinium texaphyrin, Gd (III) Texaphryin, Gd-Tex, PCI-0120, Xcytrin, Temozolomide, CCRG-81045, Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3, 4-dihydro-3-methyl-4-oxo-, M & B 39831, M and B 39831, Methazolastone, RP-46161, SCH 52365, Temcad, Temodal, Temodar, Temomedac | National Cancer Institute (NCI), Radiation Therapy Oncology Group | Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma | 02/11 | 03/11 | | |
